Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
Location status: Recruiting
Location contact
Cheng Xiangdong, MD
CONTACT
Zhiyuan Xu
CONTACT
NCT Number: NCT06078930
In this study, the investigators will prospectively recruit 100,000 individuals, including gastric cancer patients who have not undergone any anti-tumor treatment and non-gastric cancer participants. The investigators will construct a diagnostic model for malignant tumors based on the combination of tongue imaging, tongue coating, saliva, gastric juice, and fecal multi-omics data (including metagenomics, proteomics, metabolomics, etc.). Additionally, the study will explore the relationship between oral, gastric, and intestinal microbiota and the development of malignant tumors.
Interested in participating?
Request Info18 year–90 year
All sexes
Observational
Hangzhou, Zhejiang, 310022, China
Location status: Recruiting
Cheng Xiangdong, MD
CONTACT
Zhiyuan Xu
CONTACT
Patients with gastric cancer were recruited through outpatient clinics, endoscopy units, and inpatient departments of various centers, with all patients requiring a histopathological diagnosis. Non-gastric cancer participants were sourced from community health check-ups, outpatient clinics, and endoscopy units affiliated with these centers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Gastric Cancer Patients:
Exclusion criteria
for Gastric Cancer Patients:
Inclusion criteria
for Healthy Participants:
Exclusion criteria
for Healthy Participants:
Tongue images, coating, saliva, gastric juice, and feces on the tongue and clinical data of patients with gastric cancer and healthy participants will be collected.
Time frame: 5 years
Time frame: 5 years
These data of gastric cancer group included age, sex, height, weight, family history, smoking, drinking, TNM staging, tumor location, tumor size, pathological type, grade of differentiation, expression of Her2, nerve invasion, vascular tumor thrombus, lauren type and and blood tumour markers, and these data of healthy participants group included age, sex, height, weight, smoking, drinking and blood tumour markers.
Time frame: 5 years
Time frame: 5 years
Contact information is provided by the study sponsor or research team.
Xiangdong Cheng, MD
CONTACT
Zhiyuan Xu, MD
CONTACT
Zhejiang Cancer Hospital
Other
A Multi-center Observational Clinical Study on the Development of Artificial Intelligence-Based Gastric Cancer Screening and Diagnosis Technology Using Multi-Omics Analysis of Tongue Imaging and Tongue Coating
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06392750
Diagnosis, Digestive System Diseases
Yangzhou, Jiangsu, China
View Trial DetailsNCT07481110
Digestive System Diseases, Digestive System Neoplasms
Algiers, Algeria
View Trial DetailsNCT07076979
Digestive System Diseases, Digestive System Neoplasms
Shanghai, China
View Trial DetailsNCT05430841
Digestive System Diseases, Digestive System Neoplasms
Xiamen, Fujian, China
View Trial Details